The Net Margin of Vaxcell Bio Therapeutics (323990.KQ) is -559.45%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -559.45% |
| 2023-12-31 | -74865.78% |